07.02.2017 • NewsElaine BurridgeSolvayBatteries

Solvay Takes DuPont’s Energain Li-Ion Technology

(c) Solvay
(c) Solvay

Belgian chemical group Solvay has acquired DuPont’s Energain lithium-ion high voltage technology for an undisclosed sum. The Brussels-headquartered company said Energain will expand its Special Chem Global Business Unit’s existing portfolio of high-performance salts and additives for electrolytes and strengthen its development capabilities for Li-ion batteries.

Nicolas Cudré-Mauroux, Solvay’s general manager of research & innovation added that the acquisition reinforced the group’s competencies in areas such as modelling and formulations.

The advanced Li-ion battery market is developing rapidly, noted Solvay, driven by increasingly stringent regulations and continuous improvements in performance and cost.

According to a September 2016 report by US-based Transparency Market Research (TMR), a growing shift toward sustainable clean fuels in the automotive sector is a key factor driving the Li-ion battery market. TMR said rising demand for high-power capacity batteries in cars as well as increasing sales of smartphones and other consumer electronics are fuelling growth worldwide. It projects the value of the global Li-ion market to rise from nearly $30 billion in 2015 to more than $77 billion in 2024, showing a compound annual growth rate of 11.6%.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.